IBM Invests Big in Quantum Computing Amid Declining Share Price
IBM has made significant strides in its quantum computing efforts over the past few weeks. The company finalized a $1 billion award from the U.S. Department of Commerce under the CHIPS and Science Act, with IBM matching this sum with another $1 billion of its own.
The funds will be allocated to research and development at IBM's 300-millimeter quantum chip manufacturing facility in Albany, New York. This investment is part of a broader effort by IBM to establish a quantum-computing ecosystem that spans from Switzerland to upstate New York.
IBM has also been expanding its software capabilities. The company partnered with CUBE to deliver automated monitoring for AI regulation worldwide through its Regulatory Horizon Scanning feature, embedded in IBM WatsonX Governance. This feature addresses the growing challenge faced by multinationals in navigating a patchwork of country-specific rules governing algorithms and automated decision-making.
Despite this operational flurry, IBM's share price has yet to reflect these developments. The stock declined 2.5% by Friday's close, extending its year-to-date decline to 22%. Some market participants have used the news as an opportunity to lock in gains, rather than embracing the potential for growth.